Dr. Reddy's Laboratories Ltd. ADR Stock
The Dr. Reddy's Laboratories Ltd. ADR stock is trending slightly upwards today, with an increase of €0.10 (0.860%) compared to yesterday's price.
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Dr. Reddy's Laboratories Ltd. ADR stock is not clear.
With a target price of 14 € there is a slightly positive potential of 19.66% for Dr. Reddy's Laboratories Ltd. ADR compared to the current price of 11.7 €.
So far the community has only identified positive things for Dr. Reddy's Laboratories Ltd. ADR stock. The most positive votes were given for criterium "Brand".
Pros and Cons of Dr. Reddy's Laboratories Ltd. ADR in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dr. Reddy's Laboratories Ltd. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | 0.860% | -3.306% | -1.681% | -13.971% | -21.477% | -77.282% | -78.919% |
| Almirall S.A. | 0.910% | 2.160% | 7.120% | 59.422% | 63.760% | 40.329% | 22.366% |
| Orion Corp. B | -0.410% | 1.151% | 2.500% | 44.808% | 43.290% | 22.804% | 62.957% |
| Sihuan Pharmaceutical Holdings Group Ltd. | 1.450% | -3.448% | -10.256% | 71.779% | 83.007% | 23.894% | 78.344% |
Comments
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $16.90 price target on the stock, up previously from $14.44.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target lowered by analysts at Barclays PLC from $17.40 to $17.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for RDY provided by MarketBeat